|
|
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
|
7R01CA116337-03
|
$532,731
|
$133,183
|
RUBIN, MARK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-07
|
$560,698
|
$48,613
|
WHITTEMORE, ALICE
|
STANFORD UNIVERSITY
|
|
|
"Strength training, Self-efficacy, and Function in Blacks with Prostate Cancer."
|
1R21CA127784-01A1
|
$165,375
|
$41,344
|
HURLEY, BERNARD
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
|
|
"Using Perceptual Mapping to Develop Low Literacy CRC Screening Decision Aids"
|
5R21CA120122-02
|
$180,000
|
$180,000
|
GORDON, THOMAS
|
TEMPLE UNIVERSITY
|
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
1R01CA131445-01A1
|
$221,524
|
$55,381
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
|
18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma
|
5R01CA129356-02
|
$359,596
|
$89,899
|
Schuster, David
|
EMORY UNIVERSITY
|
|
|
3-D Transrectal Ultrasound with 2-D Arrays
|
1R01CA116379-01A1
|
$248,168
|
$62,042
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
3rd US/EU Conference on Repair of Endogenous Genome Damage
|
1U13CA136020-01
|
$9,000
|
$2,250
|
Mitra, Sankar
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
|
5-A-DAY CUSTOMIZED SURVEY STUDY - TASK ORDER NO. 2
|
N02PC513009-003
|
|
$0
|
HURWITZ, PAUL
|
WESTAT:1109753
|
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
1R01CA129484-01A1
|
$393,213
|
$24,576
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-15
|
$1,680,267
|
$840,134
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A genomic scan of hereditary prostate cancer families with an occurrence of colon
|
1R03CA133938-01
|
$88,000
|
$22,000
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
1R01CA122128-01A2
|
$592,812
|
$592,812
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
$361,526
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
A mouse model of stem cell deregulation and lung cancer
|
5R01CA076354-08
|
$264,921
|
$52,984
|
LOCKER, JOSEPH
|
YESHIVA UNIVERSITY
|
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-02
|
$426,676
|
$32,001
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
A New Class of Mechanistic Risk Prediction Models for Cancer Treatment Outcomes
|
1R21CA131603-01
|
$170,820
|
$42,705
|
HUANG, LI-SHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
A new method for multiplex detection of micro-RNAs (miR-ID)
|
1R43CA134277-01A1
|
$300,580
|
$75,145
|
KAZAKOV, SERGEI
|
SOMAGENICS, INC.
|
|
|
A New Tool for Discovery, Assay and Validation of Biomarkers in Prostate Cancer
|
1R43CA135903-01
|
$132,179
|
$33,045
|
Stroobant, Paul
|
DIFFERENTIAL PROTEOMICS, INC.
|
|
|
A novel function of TIMP-1
|
2R01CA089113-06A1
|
$269,442
|
$26,944
|
KIM, HYEONG-REH
|
WAYNE STATE UNIVERSITY
|
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
$70,225
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
1R01CA131137-01A1
|
$323,700
|
$80,925
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
|
A Pharmacogenetic approach to prostate cancer susceptibility
|
5R03CA128028-02
|
$74,000
|
$18,500
|
Kidd, La Creis
|
UNIVERSITY OF LOUISVILLE
|
|
|
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer
|
1R21CA128352-01A1
|
$268,452
|
$67,113
|
oh, william
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
|
5R01CA121023-02
|
$538,717
|
$538,717
|
LIANG, WENCHI
|
GEORGETOWN UNIVERSITY
|
|
|
A Population Based Policy Model for Colorectal Cancer
|
5U01CA088204-08
|
$189,755
|
$47,439
|
KUNTZ, KAREN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics
|
1F32CA132332-01A1
|
$51,278
|
$12,820
|
Nasr, Khaled
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction
|
1R01CA127735-01A1
|
$312,288
|
$78,072
|
SHENG, SHIJIE
|
WAYNE STATE UNIVERSITY
|
|
|
A Serum Marker for Aggressive Prostate Cancer
|
5R01CA121460-03
|
$427,039
|
$106,760
|
PEEHL, DONNA
|
STANFORD UNIVERSITY
|
|
|
A simple urinary assay for sensitive prognosis of disease progression and death f
|
5R21CA127671-02
|
$226,445
|
$56,611
|
HILLEGONDS, DARREN
|
UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB
|
|
|
A Standards-based Tool for Clinical Trials Protocol Authoring
|
5R21CA127507-02
|
$118,800
|
$9,801
|
EL SAADAWI, GILAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
|
5R01CA126596-02
|
$592,024
|
$148,006
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Transgenic Model for Prostate Tumor Immunity
|
5R01CA109339-05
|
$281,848
|
$70,462
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
A trial-based MISCAN model for prostate cancer
|
5U01CA115996-04
|
$181,870
|
$45,468
|
DE KONING, HARRY
|
ERASMUS MEDICAL CENTER
|
|
|
A2a receptor engagement promotes T cell tolerance
|
5R01CA114227-03
|
$254,392
|
$63,598
|
POWELL, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
$1,208,205
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
$3,138
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
$7,500
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
$219,799
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Absorbable and Low-Cost Radioseeds for Malignant Tumors
|
5R44CA121641-03
|
$431,494
|
$107,874
|
PENG, YONGREN
|
XL SCI-TECH, INC.
|
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
1R01CA133148-01
|
$454,226
|
$38,609
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
|
Accuracy of Physical Activity Measures in Cancer Studies
|
5R01CA103974-04
|
$498,756
|
$74,813
|
STERNFELD, BARBARA
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
5R01CA114075-04
|
$280,299
|
$35,037
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
|
|
Activation of the Cancer Preventive Nrf2-ARE Pathway by Seaweed
|
1R21CA133681-01A1
|
$200,906
|
$25,113
|
LUESCH, HENDRIK
|
UNIVERSITY OF FLORIDA
|
|
|
Adherence Among Older Women with Breast Cancer
|
5K07CA109064-05
|
$136,080
|
$136,080
|
GIORDANO, SHARON
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Adhesive Regulation During Cell Migration
|
5R01CA085862-09
|
$272,687
|
$13,634
|
HUTTENLOCHER, ANNA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
3R01CA116195-04S1
|
$86,800
|
$21,700
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY
|
5R01CA116195-04
|
$321,017
|
$80,254
|
BOSLAND, MAARTEN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
Adverse Drug Reactions in Geriatric Cancer Patients
|
1K01CA134554-01
|
$130,697
|
$130,697
|
MCKOY, JUNE
|
NORTHWESTERN UNIVERSITY
|
|
|
Age related ubiquitin defect on T-cell response to tumor
|
5R01CA107181-04
|
$217,978
|
$217,978
|
ZHANG, HUANG-GE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Total relevant funding to Aging for this search: $162,224,132
|
